Related Experiment Video
Updated: Dec 24, 2025

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation
Lucie Laurien1, Masahiro Nagata1, Hannah Schünke1
1Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Abstract:
Receptor interacting protein kinase 1 (RIPK1) regulates cell death and inflammatory responses downstream of TNFR1 and other receptors, and has been implicated in the pathogenesis of inflammatory and degenerative diseases. RIPK1 kinase activity induces apoptosis and necroptosis, however the mechanisms and phosphorylation events regulating RIPK1-dependent cell death signaling remain poorly understood. Here we show that RIPK1 autophosphorylation at serine 166 plays a critical role for the activation of RIPK1 kinase-dependent apoptosis and necroptosis. Moreover, we show that S166 phosphorylation is required for RIPK1 kinase-dependent pathogenesis of inflammatory pathologies in vivo in four relevant mouse models. Mechanistically, we provide evidence that trans autophosphorylation at S166 modulates RIPK1 kinase activation but is not by itself sufficient to induce cell death. These results show that S166 autophosphorylation licenses RIPK1 kinase activity to induce downstream cell death signaling and inflammation, suggesting that S166 phosphorylation can serve as a reliable biomarker for RIPK1 kinase-dependent pathologies.
Insights
Receptor interacting protein kinase 1 (RIPK1) autophosphorylation at serine 166 is crucial for RIPK1 kinase-dependent apoptosis, necroptosis, and inflammatory diseases. This S166 phosphorylation acts as a biomarker for RIPK1-driven pathologies.
Area of Science:
- Molecular biology
- Cellular signaling
- Immunology
Background:
- Receptor interacting protein kinase 1 (RIPK1) is a key regulator of cell death and inflammation.
- RIPK1 kinase activity is implicated in inflammatory and degenerative diseases.
- Mechanisms of RIPK1-dependent cell death signaling are not fully understood.
Purpose of the Study:
- To investigate the role of RIPK1 autophosphorylation in regulating RIPK1 kinase activity.
- To determine the impact of RIPK1 phosphorylation on apoptosis and necroptosis.
- To assess the in vivo relevance of RIPK1 phosphorylation in inflammatory pathologies.
Main Methods:
- Site-directed mutagenesis to study RIPK1 phosphorylation at serine 166 (S166).
- In vitro kinase assays to measure RIPK1 activity.
- In vivo mouse models of inflammatory diseases.
Main Results:
- RIPK1 autophosphorylation at S166 is critical for RIPK1 kinase-dependent apoptosis and necroptosis.
- S166 phosphorylation is required for RIPK1 kinase-dependent pathogenesis in vivo.
- S166 phosphorylation modulates RIPK1 kinase activation but is insufficient to induce cell death alone.
Conclusions:
- S166 autophosphorylation licenses RIPK1 kinase activity to induce cell death and inflammation.
- RIPK1 S166 phosphorylation is a critical event in RIPK1-dependent pathologies.
- S166 phosphorylation serves as a potential biomarker for RIPK1 kinase-dependent diseases.
More Related Videos
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
08:55Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...